Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
02 juil. 2024 16h05 HE
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and...
Europe Biologics CDMO Market Research 2023-2032: Companies that Skillfully Navigate Regulatory Complexities and Adopt Technological Innovations are Well-Positioned for Significant Success
01 juil. 2024 05h09 HE
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Biologics CDMO Market: Focus on Cell Type, Molecule Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ...
Nucleic Acid Therapeutics CDMO Market Research Report 2024-2034 Featuring Strategic Analysis of Lonza Group, Catalent, and Thermo Fisher Scientific Among Others
28 juin 2024 10h23 HE
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Nucleic Acid Therapeutics CDMO Market" report has been added to ResearchAndMarkets.com's offering.The global nucleic acid therapeutics CDMO...
Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management
27 juin 2024 09h00 HE
|
Blue Mountain
Blue Mountain and Zifo announce a partnership to enhance efficiency and innovation in the life sciences sector, offering advanced solutions for GMP.
Japan Contract Development Manufacturing Organization Market Report 2024-2030, Featuring Lonza, Recipharm, LabCorp, Catalent, WuXi AppTec, CordenPharma, Cambrex, Bushu Pharmaceuticals and Nipro
21 juin 2024 04h50 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Japan Contract Development Manufacturing Organization Market Size, Share & Trends Analysis Report by Product Type (API, Drug Product), Workflow...
Longeveron® Announces Contract Development and Manufacturing Business and First Contract
03 juin 2024 09h00 HE
|
Longeveron
Longeveron launches contract development and manufacturing business for stem cell therapies. 15,000 sf state-of-the-art GMP facility with 8 cleanrooms.
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
28 mai 2024 07h00 HE
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
Key Growth Opportunities in the Oral Solid Dosage Formulation Industry - Fixed Dose Combination Products for Chronic Diseases, Medical Cannabidiol and Phase-appropriate Services for Orphan Drugs
27 mai 2024 04h35 HE
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Oral Solid Dosage Formulation Industry" report has been added to ResearchAndMarkets.com's offering. This analysis...
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
23 mai 2024 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering
22 mai 2024 08h16 HE
|
BioConnection
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering Strategic partnership provides a...